University of Oxford

A co-founder of Oxagen, John is Regius Professor of Medicine at Oxford University. He is a Non-Executive Director of Roche, a member of the Science Advisory Board of AstraZeneca and is the Founder of the Wellcome Trust Centre for Human Genetics. He has founded or advised a number of other biotechnology and pharmaceutical businesses worldwide.

Brenda Buttner is a senior business correspondent at FOX News Channel. She contributes to Your World with Neil Cavuto, Cavuto on Business and serves as a substitute business anchor. Buttner also hosts the FNC weekend show Bulls & Bears, which highlights what investors need to know before Monday's opening bell. She was formerly the host of The Street.com, a fast-paced FOX News business show featuring action-oriented advice on how to get an edge on Wall Street. Before joining FNC, Buttner was at CNBC, where she hosted The Money Club and served as a general and Washington correspondent. She is the recipient of numerous awards, including a Cable Ace Award in 1996 for Best Business Programming and a National Clarion award in 1990 for Best News Story. Buttner's personal finance articles have been published in many popular magazines and newspapers including The New York Times and Ladies' Home Journal. Buttner began her career as an anchor/reporter for KCRL-TV (NBC) in Reno, Nev. She graduated from Harvard University with honors with a bachelor's degree in social studies. Buttner went on to be a Rhodes Scholar at Oxford University, where she graduated with high honors with a bachelor's degree in politics and economics.

Robbin Johnson retired from Cargill effective January 1, 2007. He was elected Senior Vice President, Corporate Affairs, in June 2000. In that role he worked with Cargill's senior leadership team on public policy and communications strategies. Johnson currently is President of The Cargill Foundation and serves on the boards of the Minnesota Early Learning Foundation, Second Harvest Heartland and the International Food and Agricultural Trade Policy Council. He is past chair of the U.S. Feed Grains Council and the Canada-Minnesota Business Council. Johnson Currently is Senior Policy Advisor, Global Policy Studies at the University of Minnesota's Humphrey Institute of Public Affairs. Johnson joined Cargill in 1971. He was named an assistant vice president in 1976, vice president, Administrative Division, in 1982 and was elected Corporate Vice President, Public Affairs, in 1993. Johnson graduated from Yale University in 1968 with a bachelor's degree, did graduate study as a Rhodes Scholar at Oxford University in England from 1968 to 1970 and attended Yale Law School from 1970 to 1971. Johnson was involved in the development of the first APEC Food System proposal ten years ago and worked with ABAC members to advance its recommendations.

Dee Athwal leads the Research and Development activities. Prior to joining moksha8, he was Vice President of Business Development at Celltech-UCB Group from 1998 to 2006 and was involved in the $2.5BB merger between Celltech and UCB. Mr. Athwal is a world-renowned expert in the antibody field responsible for designing every humanized antibody that Celltech has put into clinical development over the past 15 years. During his 25-year tenure at Celltech-UCB Group, he was instrumental in the advancement of the key development programs and in the establishment of some of the biotech / pharmaceutical industry's largest collaborations with organizations such as Amgen, Biogen and Imclone. Mr. Athwal is a visiting lecturer at Kings College, Sheffield University, Oxford University and Nottingham University. He speaks three languages and is based in London.

Steven H. Holtzman is a founder, Chair, and Chief Executive Officer. From early 1994 - 2001, Mr. Holtzman served as an early leader and the Chief Business Officer of Millennium Pharmaceuticals, a leading biopharmaceutical company. Prior to joining Millennium, from 1986-1994, Mr. Holtzman was a founder, the first employee, and Executive Vice President of DNX Corporation, the first commercial enterprise devoted to the development of agricultural, biomedical, and pharmaceutical applications of transgenic animal technology. Prior to DNX, in the early 1980s, Mr. Holtzman conceived of and was the founding Executive Director of the Ohio Edison Program, the nation's first state government program directed to achieving economic development through funding young technology-based ventures and university/industry collaborative research and development efforts. In the late 1970s, Mr. Holtzman was an instructor and tutor in moral philosophy and the philosophy of language at Corpus Christi College, Oxford University, U.K. Mr. Holtzman co-founded and from 1995-2000 was the Co-Chair of the Biotechnology Industry Organization (BIO) Bioethics Committee. From 1996-2001, he served as a presidential appointee to the National Bioethics Advisory Commission, the principal advisory body to the President and Congress on ethical issues in the biomedical and life sciences. He is a member of the Board of Directors of Anadys Pharmaceuticals, Inc. and of BIO. He is a Trustee of The Hastings Center for Bioethics and a Trustee of the Berklee College of Music. Mr. Holtzman received his B.A. in Philosophy from Michigan State University and his B.Phil. graduate degree in Philosophy from Oxford University, which he attended as a Rhodes Scholar.

Victor Blank is now chairman of Lloyds TSB Group, having joined the board in March 2006. He was knighted in the New Year's Honours List in 1999 for services to the financial industry and is a member of the Financial Reporting Council and the CBI Boardroom Issues Group. Outside business, Victor Blank is actively involved in a number of educational, charitable and communal activities. At the University of Oxford, he is a Member of Council, Trustee of the Said Business School, advisor to the Environmental Change Institute, an Honorary Fellow of St. Catherine's College and Vice President of Oxford Philomusica. He is also Chairman of Governors of University College School in London and a Governor of Tel Aviv University. His charitable interests include Wellbeing of Women, (the Royal College of Obstetricians and Gynaecologists' health research charity) and UJS/Hillel, both of which he chairs, and membership of the Advisory Board of the United Jewish Israel Appeal. He is also a member of the Advisory Council of the Orchestra of the Age of Enlightenment.

ADRIAN L. HARRIS, M.D. is Cancer Research UK Professor of Clinical Oncology at the University of Oxford, and Director of the Cancer Research UK Molecular Oncology Laboratories at the University s Weatherall Institute of Molecular Medicine. He is involved in clinical trials of anti-angiogenesis therapy, signal blockade inhibitors and immunotherapy. His clinical research interests include breast cancer, melanoma, and renal cancer.

Pat House has more than 30 years of industry experience in a variety of marketing, operations and executive positions. In addition to Shutterfly, House currently serves on the Board of Directors at BDNA Corporation, The Meth Project, The Energy Free Home Challenge, and The Mary Mae Foundation. Ms. House co-founded and served as Vice Chairman of Siebel Systems, the world's leading provider of eBusiness application software, where she held a variety of executive positions at the company, including executive vice president. Prior to joining Siebel, she held managerial and executive positions at Verbatim Corporation, Oracle Corporation, and Frame Technology Corporation. A frequent industry spokesperson and guest professor at Stanford University and Oxford University, Ms. House is co-author of the business best seller Cyber Rules. She has been named one of Fortune's 50 Most Powerful Women and Entrepreneur of the Year by the Forum of Women Entrepreneurs. House earned a BA in Education from Western Michigan University.

Dr. Herman Waldmann is a co-founder of Tolerx, has served as one of our directors since our inception in July 2000, and is Chairman of our Scientific Advisory Board. Dr. Waldmann has been a Professor of Pathology, Head of the Sir William Dunn School of Pathology at the University of Oxford and Clinical Director of the Therapeutic Antibody Centre (TAC), University of Oxford since 1994. Prior to that, Dr. Waldmann was a professor at the University of Cambridge. Dr. Waldmann holds a Ph.D. from the University of Cambridge and is a Fellow of the Royal College of Pathology, a Member of the Royal College of Physicians, a Fellow of the Royal Society, and a Fellow of the Academy of Medical Sciences.

Leslie Iversen (PhD) is Director of the Wolfson Centre for Research on Age-Related Diseases at Kings College London, Visiting Professor at the Department of Pharmacology, University of Oxford, and founder of the pharmaceutical company Panos Therapeutics Ltd. He was previously Director of the Neuroscience Research Centre set up by the international pharmaceutical company Merck & Co Inc in Harlow, Essex, UK (1983-1995) and Director of the UK Medical Research Council Neurochemical Pharmacology Unit in Cambridge, England (1970-1983). He is the author of several books and of more than 350 scientific publications and is a Fellow of the Royal Society of London and a Foreign Associate of the National Academy of Sciences, USA. He acted as the specialist adviser to the House of Lords Science & Technology Committee's enquiry into Cannabis, 1998 and his most recent books are "The Science of Marijuana", Oxford University Press, 2000 and "A Very Short Introduction to Drugs", Oxford University Press, 2001.

Denis Galligan is Professor of Socio-Legal Studies at the University of Oxford and Director of the Centre for Socio-Legal Studies. He came to Oxford as an Australian Rhodes Scholar and has taught at various universities in Britain and Australia. He has had extensive experience in Central and east Europe in research and in advising governments and international bodies on law, government, and public administration. His research interests are in public law, the role of law in society, legal theory, and constitutional law. He is a Professorial Fellow of Wolfson College. He holds appointments as Visiting Professor of Public and International Affairs at the Woodrow Wilson School of Princeton University; he is Jean Monnet Professor at Universita degli Studi di Siena.

David is Deputy Director of the Social Disadvantage Research Centre at the University of Oxford. He is a member of the research team that developed the Indices of Deprivation 2004, in which he led on the Crime Domain and the small area population estimation. His major research interests include the mapping and tracking of poverty and wider social deprivation, with a particular focus on the effects of crime and disorder on individuals and communities.

Giles Kerr was appointed a Director of Elan in September 2007. He is currently the Director of Finance with the University of Oxford, England, and a Fellow of Keble College. He is also a Director and Chairman of the Audit Committee of Victrex plc and a Director of BTG plc, Isis Innovation Ltd and a number of private companies. Previously, he was the Group Finance Director and Chief Financial Officer of Amersham plc, and prior to that, he was a partner with Arthur Andersen in the United Kingdom.

Abdal Hakim Murad graduated from Cambridge University with a double-first in Arabic in 1983. He then lived in Cairo for three years, studying Islam under traditional teachers at Al-Azhar, one of the oldest universities in the world. He went on to reside for three years in Jeddah, where he administered a commercial translation office and maintained close contact with Habib Ahmad Mashhur al-Haddad and other scholars from Hadramaut, Yemen. In 1989, Abdal Hakim returned to England and spent two years at the University of London learning Turkish and Farsi. Since 1992 he has been a doctoral student at Oxford University, specializing in the religious life of the early Ottoman Empire. He is currently Secretary of the Muslim Academic Trust (London) and Director of the Sunna Project at the Centre of Middle Eastern Studies at Cambridge University, which issues the first-ever scholarly Arabic editions of the major Hadith collections. Abdal Hakim is the translator of a number of works, including two volumes from Imam al-Ghazali's Ihya Ulum al-Din (The Revival of the Religions Sciences). He gives lectures and leads study groups from time to time and taught the works of Imam al-Ghazali at the Winter 1995 Deen Intensive Program in New Haven, CT. He appears frequently on BBC Radio and writes occasionally for a number of publications, including The Independent, Q-News International (Britain's premier Muslim Magazine) and Seasons (the semi-academic journal of Zaytuna Institute).

Adrian Beecroft has a degree in physics from Queen's College, Oxford. Following graduation in 1968, he worked for ICL in the computer industry for five years. In 1974 he went as a Harkness Fellow to the Harvard Business School, graduating in 1976, before joining the Boston Consulting Group in London. He became a Vice President of BCG Worldwide in 1982. Adrian joined Apax in 1984 when it had 10m under management. He helped indentify and evaluate opportunities, and negotiate and close investments in promising early-stage, high tech businesses. As Apax grew, Adrian assumed responsibility for the London office and approval of all investments. He played a major part in the international expansion of the business, which now has over $20 billion under management with over 150 professionals in eight countries. Until recently Adrian was the company's chief investment officer. He was Chairman of the British Venture Capital Association in 1991/92 and has represented Apax on the boards of over 20 private and public companies. Adrian is a sponsor of the Beecroft Institute of Particle Astrophysics and Cosmology at Oxford University, as well as sponsoring a new academy school outside of Oxford. He is also a Fellow of the Institute of Physics. He is a trustee of Impetus Trust, a charity focused on venture philanthropy, and was appointed Chairman of the Cricket Foundation in 2008.

Alan is also committed to theatre-in-the-round, for which he has written the vast majority of his plays. It is always worth remembering that when he stages a play in London or any are performed in the proscenium arch, it is a step away from the author's original intention. It has frequently been stated that the definitive production of Alan's plays is the premiere production in the round in Scarborough. Alan has a close relationship with Scarborough, where he lives and has worked for most of his professional career. He has been artistic director of what is now the Stephen Joseph Theatre since 1972 and has premiered all but four plays (Christmas V Mastermind, Mr Whatnot, Jeeves and A Small Family Business) in Scarborough. More than half his plays have gone on to London to be produced in the West End or at the National Theatre. At one point in 1975, he held the record for having the most professional productions being performed simultaneously in the West End (The Norman Conquests, Absurd Person Singular and Absent Friends). His work has been translated into more than 35 languages and his plays are regularly performed throughout the world. He has received more than 25 awards and honours including an Olivier, a Moliere, the Variety Club of Great Britain Playwright of the Year and the Writers' Guild of Great Britain Lifetime Achievement Awards. The 1992 Cameron Mackintosh Professor of Contemporary Theatre at Oxford University, he is now Visiting Professor at the University of Hull. In 1994, he received a Montblanc de la Culture Award for Europe for 'establishing a thriving theatrical tradition in Scarborough and for his dedication and commitment to it'. In addition to holding a number of honorary degrees, he was appointed a CBE in 1987 and in 1997 was knighted for services to the theatre. Alan's plays have been regularly produced in America and more than 10 of his plays have been produced on Broadway and Off-Broadway. In 1975 he held the record of having the most plays simultaneously running on Broadway (The Norman Conquests and Absurd Person Singular) His greatest success in America came in 2005, when Alan took his Scarborough company to the 59E59 Theaters' Brits Off Broadway Festival to present Private Fears In Public Places. The month-long run was an unprecedented success receiving great acclaim from audiences and critics alike. The New York Times proclaimed it "altogether wonderful" and the cast "flawless". In February 2006, Alan suffered a stroke but later that year was directing his new play If I Were You and co-directing a revival of Mr A's Amazing Maze Plays at the Stephen Joseph Theatre, Scarborough. In June 2007, he announced he was to step down as the Artistic Director of the Stephen Joseph Theatre and will officially leave the position in March 2009 **, but intends to continue to direct the premieres of his new plays and revivals at the theatre. In 2008, Alan will premiere the first new play he has written since his stroke, Life And Beth, and it will form part of a summer season also featuring his plays Haunting Julia and Snake In The Grass.

Professor Allen Hill, FRS is internationally recognised as an expert in the field of electrochemistry and biosensors. He was an inventor/founder of Medisense who commercialised the first glucose sensor for monitoring diabetes. The company was sold to Abbott Diagnostics for $780m. Professor Hill is also the founder of Oxford BioSensors who are developing testing kits for cardiac markers.

Alun Edwards is a qualified librarian who has pursued an unusual career leading to work on various JISC or AHRC funded projects at Oxford University. Previously the manager of Humbul and now collections development manager for Intute: Arts and Humanities, Alun is involved in promoting critical thinking about resources available on the Internet. For the First World War Poetry Digital Archive, Alun assists in the research of collections to be digitised and is primarily responsible for identifying other scholarly resources to be fed into the archive via Intute.

Andrew Carr has been the Nuffield Professor of Orthopaedic Surgery and Head of Department at the University of Oxford since 2001. He is a member of the Research Committee of the Royal College of Surgeons of England and the Executive and Research Committees of the European Shoulder and Elbow Surgery Society. He is Deputy Chairman of the Board of Trustees of the Arthritis Research Campaign (arc). He is a trustee of the Lord Nuffield Trust and the Nuffield Orthopaedic Centre Appeal. He is an Associate Editor of the Journal of Bone and Joint Surgery. He is a non-executive director of the Nuffield Orthopaedic Centre NHS Trust and a member of the Hospital Trust Board.

Andrew J. Pollard is Professor of Paediatric Infection and Immunity in the Department of Paediatrics, and Director of the Oxford Vaccine Centre at Oxford University. He is an Honorary Consultant Paediatrician at Oxford Children's Hospital, a Fellow of St Cross College and a Jenner Institute Investigator. He directs the largest paediatric vaccine clinical trials group in the UK, linked to his laboratory research group, which is located in the Centre for Clinical Vaccinology and Tropical Medicine. He also works on serogroup B meningococcal vaccine development (group B meningococcal infection is the leading infectious cause of death in early childhood in the UK) and with collaborators in Oxford, Manchester and at the National Institute for Biological Standards and Control, which is planning a phase 1 trial of a novel meningococcal vaccine. In 2005, he established a research group at Patan Hospital in Kathmandu, Nepal, which studies vaccine preventable diseases in an urban setting in the country. The studies in Nepal highlighted the particular problem of typhoid in children. Professor Pollard has developed a bactericidal assay, which is being used to study population immunity in the country. In Oxford, in collaboration with the University of Maryland, the group is developing a typhoid challenge model to study pathogenesis of typhoid infection, examine the correlates of protection and evaluate new vaccines. Professor Pollard is also the director of an annual 3-day course held in Oxford, 'Hot topics in Infection and Immunity in Children' (widely known as 'the Oxford Course'), which has become a major feature in the annual calendar of the European Society for Paediatric Infectious Disease and attracts more than 200 delegates every year. Building on the success of this course, an Oxford University Postgraduate Diploma in Paediatric Infectious Disease was launched in 2008. Professor Pollard obtained his medical degree at St Bartholomew's Hospital Medical School, University of London in 1989 and trained in Paediatrics at Birmingham Children's Hospital. He specialised in Paediatric Infectious Diseases at St Mary's Hospital, London, and at British Columbia Children's Hospital, Canada. He obtained his PhD at St Mary's Hospital, London in 1999, studying immunity to Neisseria meningitidis in children, and proceeded to work on anti-bacterial innate immune responses in children in Canada before returning to his current position at the University of Oxford, in 2001. His publications include over 200 manuscripts and books.

Professor Andrew Smith is a Professor in the Department of Plant Sciences at the University of Oxford. He helped with developing the Op Wall bromeliad research project in the Cusuco National Park in Honduras. His research interests are in the cellular and molecular basis of plant responses to environmental stress. This work includes studies of plant adaptations to arid, saline and metal-rich environments, especially at the level of transport and sequestration of metabolites and ions.

Dr. Angela Vincent is professor of Neuroimmunology and honorary consultant in immunology in the department of clinical neurology at University of Oxford. Qualified in London, and spent 10 years at University College London with Ricardo Miledi FRS studying acetylcholine receptors. Joined John Newsom-Davis FRS at the Royal Free Hospital in London and helped to establish a research group into myasthenia gravis. Moved to Oxford in 1988 and since 1998 has been head of the Neurosciences Group at the Weatherall Institute of Molecular Medicine. The group investigates autoimmune diseases of the nervous system, by a combination of molecular biology, immunochemistry, biochemistry, electrophysiology and immunology.

Anthony Heath is a Professor of Sociology at Oxford University. His research interests are Sociology of Education and Ethnicity, Social Mobility, Political Sociology, Cross National Research with a special interest in India. The prime areas of his lecturing have been Research Design, Ethnicity and Nationalism, Sociology of Education. His publications include Ireland North and South: Perspectives from Social Science (1999), 'British National Sentiment', British Journal of Political Science (1999), 'The Need of Data Analysis for Rational Action Theory: Pros and Cons' (1998), just to name a few.

Barbara Harrell-Bond (DPhil, Oxford University) is an anthropologist of law with many years of research experience in West Africa prior to her founding the Refugee Studies Programme (now the Refugee Studies Centre RSC) at the University of Oxford. She directed the Centre from 1982-96. After her retirement from Oxford she has been involved in establishing similar academic programmes in Uganda (Makerere University, Kampala) and Egypt (American University in Cairo) where she has also established legal aid projects for refugees. In 2004, Barbara Harrell-Bond was elected as an Honorary Fellow at Lady Margaret Oxford College Hall for her contribution to the field of refugee studies. In 2005, she was listed on the Queen Elizabeth's Honours list as an Officer of the Order of the British Empire for her services to refugee and forced migration studies.

Prof. Davis is a Professor of Chemistry at the University of Oxford where he also completed his DPhil. After a two year postdoctoral position at the University of Toronto he became a Lecturer at the University of Durham, UK. In 2001 he returned to the University of Oxford and received a fellowship at Pembroke College. His research group focuses on chemical biology, carbohydrates and proteins. This work has received the RSC Meldola medal and prize 1999, RSC Syngenta Carbohydrate Award 2001, the AstraZeneca Strategic Research Award, a DTI Smart Award, a Mitzutani Foundation for Glycoscience Award, the Philip Leverhulme Prize 2003, the Royal Society Mullard Award 2005, and the RSC Corday-Morgan medal and prize 2005.

Brian is Emeritus Professor of Engineering Science at the University of Oxford. He was the scientific founder of PowderJect plc, which was established in 1993 to develop needle-free delivery of drugs and DNA in dry powder form.

Brian Follett is Chairman of the Arts and Humanities Research Council and also of the UK's Teacher Training Agency. He is a Professor in the Department of Zoology at the University of Oxford. Previously, he was Vice-Chancellor of Warwick University (l993 2001). He was knighted in 1992, and served as Biological Secretary of the Royal Society (UK's Academy of Sciences) 1987 1993. He has published approximately 300 scientific papers on biological clocks and seasonal reproduction. He chaired two national committees charged with improving academic library structures in the UK.

Chris Brooke is the Isaiah Berlin Research Fellow in the Department of Politics and International Relations at the University of Oxford, and a Fellow of Balliol College. He blogs at the Virtual Stoa.

Chris Lintott is an astronomer at the University of Oxford, where he runs the Galaxy Zoo project. He is best known as co-presenter of the BBC's long-running Sky at Night program, a position which has taken him from Hawaii to Germany and from the Canary Islands to Chile

Professor Colin Whitehouse is currently STFC's Deputy Chief Executive. He joined CCLRC as Director of Engineering in May 2003, before becoming Director of Daresbury Laboratory from April 2004 to December 2005. His personal field of research relates to advanced semiconductor materials, nanotechnology and next-generation device structures. At CCLRC, Colin is a member of the executive board and also of the Board of CLIK, CCLRC's new commercial exploitation company, and is also responsible for all of CCLRC's Knowledge Transfer activities, including the development of the new national Science and Innovation Campuses at Daresbury and Harwell, which were announced by the Treasury in the March 2006 Budget statement. He is a visiting Professor in the Department of Materials at Oxford University and in the School of Engineering at Birmingham University. He is also a member of the MoD-DTI National Advisory Committee for Electronic Materials and Devices.

Daniel Walker Howe is Rhodes Professor of American History Emeritus at Oxford University and Professor Emeritus of History at the University of California, Los Angeles. His recent book, What Hath God Wrought: The Transformation of America, 1815 1848, published by Oxford University Press, was awarded the Pulitzer Prize for 2008, the annual American History Prize of the New-York Historical Society, and the annual Prize of the Society for Historians of the Early American Republic.

David Deutsch is a physicist at the University of Oxford. He is a non-stipendiary Visiting Professor in the Department of Atomic and Laser Physics at the Centre for Quantum Computation, Clarendon Laboratory. He pioneered the field of quantum computers, and is a proponent of the many-worlds interpretation of quantum mechanics.

David Kerr is Rhodes Professor of Cancer Therapeutics and Clinical Pharmacology at the University of Oxford and President elected of European Society of Medical Oncology. He has an international reputation for treatment of and research into colorectal cancer and he is developing new approaches to cancer treatment which involve gene therapy. Professor Kerr has published more than 350 articles in peer-reviewed journals and has contributed to many books on cancer. He is Editor-in-Chief of Annals of Oncology, Europe's premier medical oncology journal. In 2005, he chaired the advisory group which has produced a 20 year plan for Scotland's NHS.

David is Professor of Diabetic Medicine at the University of Oxford and Chairman of the Oxford Centre for Diabetes, Endocrinology and Metabolism and divides his time between research, teaching and clinical care. He advises the company on clinical matters including the design and execution of the clinical trials to test the safety and efficacy of needle-free delivery of glucagon with the Particle Therapeutics Device.

David Robertson is Professor in the Department of Politics and International Relations at Oxford University. He is Vice-Principal of St Hugh's College, Oxford. The author of numerous books on British politics, with a particular interest in defense and security issues, his web page can be found here.

David Sherrington is Wykeham Professor of Physics Emeritus at the University of Oxford, having held extended appointments also in Manchester, La Jolla, London, Grenoble and Los Alamos. His research interests have been broadly based throughout Condensed Matter Theory; including metals, semiconductors, magnetism, superfluidity and especially statistical physics of complex systems in which combinations of microscopic disorder and frustration lead to interesting cooperative behaviour. A model that he introduced as a soluble spin glass is the highly-cited paradigm and the stimulus for the development of concepts and methodologies that have expanded throughout many examples of complex systems in many manifestations, in physical systems, computer and information science, biology, economics and social science. He holds Fellowships of the Institute of Physics, American Physical Society and The Royal Society. He gave the Royal Society's Bakerian Lecture (premier prize lecture in the physical sciences) in 2001 and was awarded the UK Institute of Physics Dirac Medal and Prize (premier award in theoretical physics) in 2007.

DAVID TROTT is the president and managing attorney of Bingham Farms-based Trott & Trott, P.C. Recognized as one of the nation's largest law firms handling residential default procedures, Trott & Trott represents mortgage bankers in Michigan as well as banks, credit unions, mortgage servicers, regional property owners, investor groups and individual entrepreneurs. David graduated from the University of Michigan in 1981 after spending a year at Oxford University and is a 1985 graduate of Duke University's School of Law. In 1990, Mr. Trott prepared and delivered seminars on matters relating to mortgage servicing to the MBAM and to all of the Michigan field offices of the Department of Housing and Urban Development. In 1991, he served on an Advisory Committee to the United States Bankruptcy Court that was responsible for reviewing and revising the Local Rules for the Eastern District of Michigan. He also served on a similar committee for the State District Court in Detroit. This committee made recommendations on how to simplify and streamline the eviction process. In 1992, David served as the Chairman of the Loan Administration Committee for the Mortgage Bankers Association of Michigan (MBAM) and, in 1993, he served as Chairman of the Convention Committee. David was chosen the Outstanding Mortgage Banker of the Year for 1993 by the Mortgage Bankers Association of Michigan. In 1994, David participated on the "Free Legal Advice" panel at the National Servicing Conference. He spoke on the Fair Debt Collection Practices Act and Lender Liability arising from Force Placed Hazard Insurance. David was elected to the Board of Governors for MBAM and completed his term as President of the Association in November 1997. In that same year, he was selected as one of Crain's Detroit Business' 40 Under 40 and he chaired MBAM's Affordable Housing Committee.

David Vines is Professor of Economics at the University of Oxford and a Fellow of Balliol College. He is also Adjunct Professor of Economics in the Research School of Pacific and Asian Studies at the Australian National University, and a Research Fellow of the Centre for Economic Policy Research. David's research is on macroeconomics and international economics, in particular on European monetary union, and on regional integration in the Asia-Pacific region. He is also working on the prevention and resolution of international financial crises, on regionalism in trade, and more generally, on international financial institutions and global economic governance. From 1985 to 1992 David was Adam Smith Professor of Political Economy at the University of Glasgow, and from 1994 to 2000 he was the Director of the ESRC Research Programme on Global Economic Institutions in the UK. David was a Director of Channel Four Television from 1986 to 1992, and more recently he has been a Director of Oxford Policy Management, a consultancy company which specialises in providing policy advice to international aid agencies and to governments of emerging market economies.

Deborah is an academic and writer whose specialist subject is the English language. Since 1983 she has taught English and linguistics at universities in the UK, US and Sweden, as well as being involved in a number of programmes specifically for ELT professionals in Eastern Europe and in Malaysia. She is currently Professor of Language and Communication at the University of Oxford.